← Leaderboards
Tonio Pera
Thomas Jefferson University
$2,545,123
Attributed
$2,545,123
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $595.1K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,545,123 · 1
By mechanism
R01$2,545,123 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Raymond B. Penn$20,418,451
- Jeffrey L Benovic$31,875,251
- Pawan Sharma$1,889,714
- Stephen P Peters$7,030,989
Others in their field
Other Emerging Leaders on “Genetic”
- Leonard Freedman · Leidos Biomedical Research, Inc.$89,060,933
- Ted Ross · University Of Georgia$68,763,143
- Scott Topper · Broad Institute, Inc.$64,989,588
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Dale Sandler · Social And Scientific Systems, Inc.$43,209,852
Research focus
GeneticGtp-Binding ProteinsDrug DiscoveryGenesGrowthClinical ApplicationCysteinyl Leukotriene ReceptorDrug DevelopmentEventExperimental StudyG-Protein-Coupled ReceptorsClinical ManagementAntagonist GAcetylcholineAirway HyperresponsivenessArrestinsAsthmaBiologyCell PhysiologyCellsCell Surface ReceptorsBeta-ArrestinAgonistIn Vivo Model
Grant awards (6)
Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy$595,123
R01 · FY2025 · HL · contact PI
Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy$390,000
R01 · FY2022 · HL · contact PI
Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy$390,000
R01 · FY2021 · HL · contact PI
Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy$390,000
R01 · FY2020 · HL · contact PI
Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy$390,000
R01 · FY2019 · HL · contact PI
Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy$390,000
R01 · FY2018 · HL · contact PI